Irbesartan Jubilant 150 mg
As listed in the register: Irbesartan Jubilant 150 mg, filmomhulde tabletten
150 mg · filmomhulde tablet
- Prescription only
- Heart, blood pressure and circulation
- Active substance
- Irbesartan
- Made by
- Jubilant Pharmaceuticals N.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Avapro). It describes the substance, not this exact product.
Angiotensin II is a potent vasoconstrictor formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II).
Angiotensin II is the primary vasoactive hormone of the renin-angiotensin system, and an important component in the pathophysiology of hypertension.
Irbesartan is metabolized via glucuronide conjugation and oxidation.
Irbesartan and its metabolites are excreted by both biliary and renal routes.
Food does not affect the bioavailability of irbesartan.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-24
Safety of the active substance
From the US prescribing label for the same active substance (Avapro). It describes the substance, not this exact product.
WARNING: FETAL TOXICITY When pregnancy is detected, discontinue AVAPRO as soon as possible [see Warnings and Precautions (5.1) and Use in Specific Populations (8.1) ].
- AVAPRO is contraindicated in patients who are hypersensitive to any component of this product.
- Do not coadminister aliskiren with AVAPRO in patients with diabetes.
- Hypersensitivity to any component of this product.
- ( 4 ) Coadministration with aliskiren in patients with diabetes.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States24 matching products
European UnionNo exact match for this strength and form
Spain25 matching products
- APROVEL 150 mg · comprimido recubierto con película
- IFIRMASTA 150 mg irbesartan · comprimido recubierto con película
- IRBESARTAN ALMUS 150 mg · comprimido recubierto con película
- IRBESARTAN ALTER 150 mg · comprimido recubierto con película
- IRBESARTAN AUROVITAS 150 mg · comprimido
- IRBESARTAN CINFA 150 mg · comprimido
- IRBESARTAN COMBIX 150 MG · comprimido recubierto con película
- IRBESARTAN DAVUR 150 mg · comprimido recubierto con película
Canada16 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Jubilant Pharmaceuticals N.V. |
|---|---|
| Active substance | Irbesartan |
| Used in | Heart, blood pressure and circulation |
| Strength | 150 mg |
| Form | filmomhulde tablet |
| Classification | C09CA04 · Heart, blood pressure and circulation |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Irbesartan Jubilant 150 mg, filmomhulde tabletten |
| RVG | 104620 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.